Skip to content

Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome

Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06136572
Acronym
AFFIRMATICS
Enrollment
350
Registered
2023-11-18
Start date
2024-05-06
Completion date
2026-11-05
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tourette Syndrome

Brief summary

The goal of this study is to evaluate the proportion of assertiveness difficulties in Tourette syndrome. Participants will complete several e-questionnaires (on assertiveness, Tourette severity, quality of life, self-esteem and comorbidities like depression, anxiety...).

Interventions

DIAGNOSTIC_TESTRathus Assertiveness scale

Questionnaire completion

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Tourette syndrome * Participants aged 18 years or over

Exclusion criteria

* Participants under legal protection * Inability to complete questionnaires alone

Design outcomes

Primary

MeasureTime frameDescription
Rathus assertiveness questionnaire5 minutes at inclusionThe Rathus assertiveness questionnaire includes 30 items, each scores from -3 to +30. A total score inferior or equal to -9 reveals assertiveness difficulties.

Secondary

MeasureTime frameDescription
MOVESless than 5 minutes at inclusionThe MOVES is a self-questionnaire including 20 items which measures the severity of the Tourette syndrome. Several scores are defined : motor tics, vocal tics, obsession, compulsion and other phenomena. The higher the score, the greater the severity.
HADS3 minutes at inclusionThe HADS is a self-questionnaire to assess depression (7 items) and anxiety (7 items).
ASRS-52 minutes at inclusionThe Adult AD-HD Self-Report Scale (ASRS-5) is a scale to assess the presence of Attention-Deficit / Hyperactivity Disorder. We used the first 6 items of the questionnaire for the screening of ADHD. The total score ranges from 0 to 24 and a cut off of 13 shows good screening performance.
Rosenberg Self-Esteem Scale2-3 minutes at inclusionThe Rosenberg Self-Esteem Scale is a self-questionnaire on self-esteem. It includes 10 items. The lower the score, the lower the self-esteem.
DERS5 minutes at inclusionThe Difficulties in Emotion Regulation Scale (DERS) is a self-questionnaire including 36 items. Lower scores indicate the presence of difficulties in emotion regulation.
GTS-QoL5 minutes at inclusionThe GTS-QoL is a specific Gilles de la Tourette Syndrome Quality of Life Scale. It consists of 27 items giving 6 dimensions: "Psychological", "Physical and activities of daily life", "Obsessive-compulsive", "Cognitive", "Social" and "Echo-coprophenomena", scored out of 100. The scores the highest represent a poorer quality of life.

Countries

France

Contacts

CONTACTLise Laclautre
promo_interne_drci@chu-clermontferrand.fr334.73.754.963
PRINCIPAL_INVESTIGATORIsabelle JALENQUES

University Hospital, Clermont-Ferrand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026